Har­poon, Ali­gos an­nounce PIPEs; NAYA's all-stock deal; In­vea to go pub­lic

Har­poon’s $150M PIPE: Har­poon Ther­a­peu­tics an­nounced a pri­vate place­ment that is ex­pect­ed to raise a to­tal of $150 mil­lion a month af­ter Ab­b­Vie opt­ed out of an ex­clu­sive op­tion for its BC­MA-tar­get­ing T cell en­gager in mul­ti­ple myelo­ma. The biotech did not dis­close the lead in­vestor, though it not­ed that its in­vestors in­clude Soleus Cap­i­tal, Com­modore Cap­i­tal and New Leaf Ven­ture Part­ners, among oth­ers. Its stock $HARP was down about 8% on Mon­day morn­ing af­ter the PIPE was an­nounced.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER